Skip to main content

Table 1 Clinical characteristics of the study population

From: Comparing the outcome of ileal conduit and transuretero-cutaneostomy urinary diversion after radical cystectomy: a retrospective cohort study

  IC, N = 30 TUC, N = 22 P
Mean ± SD age, years 60.5 ± 8.9 59.0 ± 9.2 0.551
Gender, n (%)    0.393
 Male 27 (90) 18 (81.8)  
 Female 3 (10) 4 (18.2)  
Pathological finding, n (%)    0.402
 Urothelial cell carcinoma 23 (76.7) 20 (90.9)  
 Squamous cell carcinoma 4 (13.3) 1 (4.5)  
 Adenocarcinoma 3 (10) 1 (4.5)  
Staging, n (%)    0.167
 Organ-confined disease (≤ pT2, pN0) 20 (66.7) 8 (36.4)  
 Extravesical disease (> pT2 or > pN0) 7 (23.3) 13 (59)  
 Metastatic disease 3 (10) 1 (4.5)  
Comorbidity, n (%)
 Cardiovascular disease 12 (40) 8 (36.4) 0.790
 Diabetes mellitus 6 (20) 3 (13.6) 0.717
 Renal insufficiency 7 (23.3) 10 (45.4) 0.093
 Anemia 21 (70) 14 (63.6) 0.629
 Hypoalbuminemia 6 (20) 8 (36.4) 0.189
Body mass index
 Underweight 24 (80) 15 (68.2) 0.389
 Norm weight 6 (20) 6 (27.3)  
 Overweight 0 1 (4.5)  
ASA score, n (%)    0.830
 2 21 (70) 16 (72.7)  
 3 9 (30) 6 (27.3)  
  1. ASA American Society of Anesthesiologist, IC ileal conduit, TUC transuretero-cutaneostomy
  2. All statistical analyses in this table used Chi-squared tests